nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—Procainamide—Sunitinib—kidney cancer	0.345	1	CrCrCtD
Probenecid—ABCC6—Dactinomycin—kidney cancer	0.0601	0.145	CbGbCtD
Probenecid—ABCB1—kidney cancer	0.0576	1	CbGaD
Probenecid—ABCC6—Vinblastine—kidney cancer	0.0376	0.0908	CbGbCtD
Probenecid—ABCC6—Doxorubicin—kidney cancer	0.0231	0.0558	CbGbCtD
Probenecid—ABCC3—Vincristine—kidney cancer	0.0178	0.0429	CbGbCtD
Probenecid—ABCC1—Dactinomycin—kidney cancer	0.0177	0.0428	CbGbCtD
Probenecid—SLC22A5—Dactinomycin—kidney cancer	0.0168	0.0407	CbGbCtD
Probenecid—ABCC4—Sorafenib—kidney cancer	0.014	0.0338	CbGbCtD
Probenecid—ABCC1—Paclitaxel—kidney cancer	0.0127	0.0305	CbGbCtD
Probenecid—ABCC4—Sunitinib—kidney cancer	0.0113	0.0274	CbGbCtD
Probenecid—ABCC3—Doxorubicin—kidney cancer	0.0111	0.0268	CbGbCtD
Probenecid—ABCC1—Vinblastine—kidney cancer	0.0111	0.0268	CbGbCtD
Probenecid—ABCC1—Vincristine—kidney cancer	0.0109	0.0263	CbGbCtD
Probenecid—SLC22A2—Vinblastine—kidney cancer	0.0101	0.0243	CbGbCtD
Probenecid—ABCC2—Paclitaxel—kidney cancer	0.00936	0.0226	CbGbCtD
Probenecid—ABCB1—Temsirolimus—kidney cancer	0.0089	0.0215	CbGbCtD
Probenecid—SLC22A12—nephron—kidney cancer	0.00855	0.14	CbGeAlD
Probenecid—ABCC2—Sorafenib—kidney cancer	0.00832	0.0201	CbGbCtD
Probenecid—ABCC2—Vinblastine—kidney cancer	0.00821	0.0198	CbGbCtD
Probenecid—ABCC2—Vincristine—kidney cancer	0.00808	0.0195	CbGbCtD
Probenecid—CYP3A4—Everolimus—kidney cancer	0.00789	0.0191	CbGbCtD
Probenecid—CYP2C8—Pazopanib—kidney cancer	0.0069	0.0167	CbGbCtD
Probenecid—ABCC1—Doxorubicin—kidney cancer	0.00682	0.0165	CbGbCtD
Probenecid—ABCC2—Sunitinib—kidney cancer	0.00674	0.0163	CbGbCtD
Probenecid—ALB—Erlotinib—kidney cancer	0.00638	0.0154	CbGbCtD
Probenecid—SLC2A9—nephron—kidney cancer	0.00587	0.0965	CbGeAlD
Probenecid—CYP3A4—Temsirolimus—kidney cancer	0.00533	0.0129	CbGbCtD
Probenecid—ABCC2—Doxorubicin—kidney cancer	0.00505	0.0122	CbGbCtD
Probenecid—CYP2C9—Capecitabine—kidney cancer	0.00502	0.0121	CbGbCtD
Probenecid—CYP2C8—Erlotinib—kidney cancer	0.00493	0.0119	CbGbCtD
Probenecid—ABCB1—Pazopanib—kidney cancer	0.00467	0.0113	CbGbCtD
Probenecid—CYP2C8—Paclitaxel—kidney cancer	0.00451	0.0109	CbGbCtD
Probenecid—ABCB1—Dactinomycin—kidney cancer	0.00427	0.0103	CbGbCtD
Probenecid—CYP2C8—Sorafenib—kidney cancer	0.00401	0.00967	CbGbCtD
Probenecid—Gingival pain—Everolimus—kidney cancer	0.00359	0.0587	CcSEcCtD
Probenecid—ABCB1—Gemcitabine—kidney cancer	0.00338	0.00816	CbGbCtD
Probenecid—CYP2C19—Sorafenib—kidney cancer	0.00336	0.00811	CbGbCtD
Probenecid—ABCB1—Erlotinib—kidney cancer	0.00333	0.00805	CbGbCtD
Probenecid—CYP2C9—Paclitaxel—kidney cancer	0.00315	0.00759	CbGbCtD
Probenecid—ABCB1—Paclitaxel—kidney cancer	0.00305	0.00737	CbGbCtD
Probenecid—Gingival pain—Sunitinib—kidney cancer	0.003	0.049	CcSEcCtD
Probenecid—CYP3A4—Pazopanib—kidney cancer	0.0028	0.00676	CbGbCtD
Probenecid—CYP2C9—Sorafenib—kidney cancer	0.00279	0.00675	CbGbCtD
Probenecid—ABCB1—Sorafenib—kidney cancer	0.00271	0.00655	CbGbCtD
Probenecid—ABCB1—Vinblastine—kidney cancer	0.00268	0.00646	CbGbCtD
Probenecid—ABCB1—Vincristine—kidney cancer	0.00263	0.00635	CbGbCtD
Probenecid—SLC22A2—nephron—kidney cancer	0.00257	0.0422	CbGeAlD
Probenecid—ABCB1—Sunitinib—kidney cancer	0.0022	0.0053	CbGbCtD
Probenecid—Gingival pain—Paclitaxel—kidney cancer	0.00201	0.0329	CcSEcCtD
Probenecid—CYP3A4—Erlotinib—kidney cancer	0.002	0.00482	CbGbCtD
Probenecid—SLC22A12—nephron tubule—kidney cancer	0.00184	0.0303	CbGeAlD
Probenecid—CYP3A4—Paclitaxel—kidney cancer	0.00183	0.00442	CbGbCtD
Probenecid—SLC22A12—renal system—kidney cancer	0.00168	0.0276	CbGeAlD
Probenecid—SLC22A8—nephron—kidney cancer	0.00167	0.0274	CbGeAlD
Probenecid—ABCB1—Doxorubicin—kidney cancer	0.00165	0.00397	CbGbCtD
Probenecid—CYP3A4—Sorafenib—kidney cancer	0.00162	0.00392	CbGbCtD
Probenecid—SLC22A12—kidney—kidney cancer	0.00162	0.0266	CbGeAlD
Probenecid—CYP3A4—Vinblastine—kidney cancer	0.0016	0.00387	CbGbCtD
Probenecid—SLC22A12—cortex of kidney—kidney cancer	0.00158	0.0259	CbGeAlD
Probenecid—CYP3A4—Vincristine—kidney cancer	0.00158	0.00381	CbGbCtD
Probenecid—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.00149	1	CbGdCrCtD
Probenecid—Nephrotic syndrome—Sorafenib—kidney cancer	0.00141	0.023	CcSEcCtD
Probenecid—Nephrotic syndrome—Sunitinib—kidney cancer	0.00135	0.0221	CcSEcCtD
Probenecid—SLC22A8—urine—kidney cancer	0.00134	0.022	CbGeAlD
Probenecid—CYP3A4—Sunitinib—kidney cancer	0.00132	0.00318	CbGbCtD
Probenecid—SLC2A9—nephron tubule—kidney cancer	0.00127	0.0208	CbGeAlD
Probenecid—SLC2A9—renal system—kidney cancer	0.00115	0.0189	CbGeAlD
Probenecid—CYP2C19—urine—kidney cancer	0.00112	0.0184	CbGeAlD
Probenecid—SLC2A9—kidney—kidney cancer	0.00111	0.0183	CbGeAlD
Probenecid—ABCC11—gonad—kidney cancer	0.00109	0.018	CbGeAlD
Probenecid—SLC2A9—cortex of kidney—kidney cancer	0.00108	0.0178	CbGeAlD
Probenecid—CYP3A4—Doxorubicin—kidney cancer	0.000986	0.00238	CbGbCtD
Probenecid—CYP2C9—urine—kidney cancer	0.000869	0.0143	CbGeAlD
Probenecid—Hepatic necrosis—Paclitaxel—kidney cancer	0.000757	0.0124	CcSEcCtD
Probenecid—SLC16A7—nephron tubule—kidney cancer	0.000748	0.0123	CbGeAlD
Probenecid—ABCC6—renal system—kidney cancer	0.0007	0.0115	CbGeAlD
Probenecid—ABCC6—kidney—kidney cancer	0.000677	0.0111	CbGeAlD
Probenecid—CYP3A4—urine—kidney cancer	0.000663	0.0109	CbGeAlD
Probenecid—SLC16A7—cortex of kidney—kidney cancer	0.00064	0.0105	CbGeAlD
Probenecid—SLC22A11—nephron tubule—kidney cancer	0.000638	0.0105	CbGeAlD
Probenecid—SLC10A1—renal system—kidney cancer	0.000635	0.0104	CbGeAlD
Probenecid—SLC10A1—kidney—kidney cancer	0.000614	0.0101	CbGeAlD
Probenecid—Pollakiuria—Temsirolimus—kidney cancer	0.000611	0.00998	CcSEcCtD
Probenecid—SLC16A7—gonad—kidney cancer	0.00061	0.01	CbGeAlD
Probenecid—SLC16A7—cardiac atrium—kidney cancer	0.000609	0.01	CbGeAlD
Probenecid—Haemolytic anaemia—Erlotinib—kidney cancer	0.000608	0.00994	CcSEcCtD
Probenecid—SLC22A6—nephron tubule—kidney cancer	0.000601	0.00988	CbGeAlD
Probenecid—SLCO1C1—renal system—kidney cancer	0.000597	0.00981	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Temsirolimus—kidney cancer	0.000584	0.00955	CcSEcCtD
Probenecid—Aplastic anaemia—Dactinomycin—kidney cancer	0.000582	0.00951	CcSEcCtD
Probenecid—SLC22A11—renal system—kidney cancer	0.00058	0.00953	CbGeAlD
Probenecid—SLCO1C1—kidney—kidney cancer	0.000577	0.00948	CbGeAlD
Probenecid—SLC10A1—gonad—kidney cancer	0.00057	0.00936	CbGeAlD
Probenecid—SLC22A7—renal system—kidney cancer	0.000566	0.0093	CbGeAlD
Probenecid—Haematuria—Temsirolimus—kidney cancer	0.000562	0.00918	CcSEcCtD
Probenecid—SLC22A11—kidney—kidney cancer	0.000561	0.00921	CbGeAlD
Probenecid—SLC22A2—nephron tubule—kidney cancer	0.000554	0.0091	CbGeAlD
Probenecid—SLC22A7—kidney—kidney cancer	0.000547	0.00899	CbGeAlD
Probenecid—SLC22A11—cortex of kidney—kidney cancer	0.000546	0.00897	CbGeAlD
Probenecid—SLC22A7—cortex of kidney—kidney cancer	0.000533	0.00876	CbGeAlD
Probenecid—Haematuria—Pazopanib—kidney cancer	0.00053	0.00865	CcSEcCtD
Probenecid—ABCC5—nephron tubule—kidney cancer	0.000523	0.0086	CbGeAlD
Probenecid—SLC22A6—cortex of kidney—kidney cancer	0.000515	0.00845	CbGeAlD
Probenecid—Procaine—BCHE—kidney cancer	0.000509	0.296	CrCbGaD
Probenecid—SLC22A2—renal system—kidney cancer	0.000504	0.00828	CbGeAlD
Probenecid—Erythema multiforme—Temsirolimus—kidney cancer	0.0005	0.00818	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Erlotinib—kidney cancer	0.000494	0.00808	CcSEcCtD
Probenecid—SLC22A2—kidney—kidney cancer	0.000487	0.008	CbGeAlD
Probenecid—SLC22A2—cortex of kidney—kidney cancer	0.000474	0.00779	CbGeAlD
Probenecid—Flushing—Pazopanib—kidney cancer	0.000463	0.00756	CcSEcCtD
Probenecid—Pollakiuria—Everolimus—kidney cancer	0.000454	0.00742	CcSEcCtD
Probenecid—Procainamide—ACHE—kidney cancer	0.000448	0.261	CrCbGaD
Probenecid—Toxic epidermal necrolysis—Sorafenib—kidney cancer	0.000445	0.00727	CcSEcCtD
Probenecid—Alopecia—Pazopanib—kidney cancer	0.000441	0.0072	CcSEcCtD
Probenecid—SLC16A1—renal system—kidney cancer	0.000433	0.00711	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Sunitinib—kidney cancer	0.000428	0.00699	CcSEcCtD
Probenecid—ABCC5—cardiac atrium—kidney cancer	0.000426	0.007	CbGeAlD
Probenecid—Anaemia—Temsirolimus—kidney cancer	0.000426	0.00696	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Erlotinib—kidney cancer	0.000419	0.00685	CcSEcCtD
Probenecid—SLC16A1—kidney—kidney cancer	0.000418	0.00687	CbGeAlD
Probenecid—Haematuria—Everolimus—kidney cancer	0.000418	0.00683	CcSEcCtD
Probenecid—Leukopenia—Temsirolimus—kidney cancer	0.000412	0.00674	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Dactinomycin—kidney cancer	0.000405	0.00662	CcSEcCtD
Probenecid—Anaemia—Pazopanib—kidney cancer	0.000401	0.00656	CcSEcCtD
Probenecid—ABCC3—renal system—kidney cancer	0.0004	0.00656	CbGeAlD
Probenecid—Leukopenia—Pazopanib—kidney cancer	0.000389	0.00635	CcSEcCtD
Probenecid—SLC16A1—gonad—kidney cancer	0.000388	0.00638	CbGeAlD
Probenecid—SLC16A1—cardiac atrium—kidney cancer	0.000388	0.00637	CbGeAlD
Probenecid—ABCC3—kidney—kidney cancer	0.000386	0.00635	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Sorafenib—kidney cancer	0.000377	0.00617	CcSEcCtD
Probenecid—Anaphylactic shock—Temsirolimus—kidney cancer	0.000376	0.00614	CcSEcCtD
Probenecid—Flushing—Everolimus—kidney cancer	0.000365	0.00597	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Sunitinib—kidney cancer	0.000363	0.00593	CcSEcCtD
Probenecid—ABCC4—nephron tubule—kidney cancer	0.000363	0.00596	CbGeAlD
Probenecid—SLC22A8—nephron tubule—kidney cancer	0.00036	0.00591	CbGeAlD
Probenecid—Erythema multiforme—Erlotinib—kidney cancer	0.000359	0.00587	CcSEcCtD
Probenecid—Anorexia—Temsirolimus—kidney cancer	0.000358	0.00586	CcSEcCtD
Probenecid—SLC22A1—renal system—kidney cancer	0.000356	0.00585	CbGeAlD
Probenecid—ABCC2—nephron tubule—kidney cancer	0.000351	0.00577	CbGeAlD
Probenecid—Alopecia—Vinblastine—kidney cancer	0.000349	0.00571	CcSEcCtD
Probenecid—Alopecia—Everolimus—kidney cancer	0.000348	0.00568	CcSEcCtD
Probenecid—SLC22A1—kidney—kidney cancer	0.000344	0.00565	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Dactinomycin—kidney cancer	0.000344	0.00562	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Gemcitabine—kidney cancer	0.000343	0.00561	CcSEcCtD
Probenecid—SLCO1A2—renal system—kidney cancer	0.000343	0.00563	CbGeAlD
Probenecid—Anorexia—Pazopanib—kidney cancer	0.000338	0.00552	CcSEcCtD
Probenecid—Alopecia—Erlotinib—kidney cancer	0.000336	0.00548	CcSEcCtD
Probenecid—Chlorpropamide—PTGS1—kidney cancer	0.000334	0.195	CrCbGaD
Probenecid—SLCO1A2—kidney—kidney cancer	0.000331	0.00544	CbGeAlD
Probenecid—ABCC4—renal system—kidney cancer	0.00033	0.00542	CbGeAlD
Probenecid—SLC22A8—renal system—kidney cancer	0.000327	0.00537	CbGeAlD
Probenecid—Decreased appetite—Temsirolimus—kidney cancer	0.000327	0.00534	CcSEcCtD
Probenecid—Erythema multiforme—Sorafenib—kidney cancer	0.000323	0.00528	CcSEcCtD
Probenecid—Pain—Temsirolimus—kidney cancer	0.000322	0.00525	CcSEcCtD
Probenecid—ABCC2—renal system—kidney cancer	0.000319	0.00524	CbGeAlD
Probenecid—ABCC4—kidney—kidney cancer	0.000319	0.00524	CbGeAlD
Probenecid—Anaemia—Vinblastine—kidney cancer	0.000318	0.0052	CcSEcCtD
Probenecid—Flushing—Sorafenib—kidney cancer	0.000317	0.00518	CcSEcCtD
Probenecid—Anaemia—Everolimus—kidney cancer	0.000317	0.00518	CcSEcCtD
Probenecid—SLC22A8—kidney—kidney cancer	0.000316	0.0052	CbGeAlD
Probenecid—Erythema multiforme—Sunitinib—kidney cancer	0.000311	0.00508	CcSEcCtD
Probenecid—ABCC4—cortex of kidney—kidney cancer	0.00031	0.0051	CbGeAlD
Probenecid—ABCC2—kidney—kidney cancer	0.000309	0.00507	CbGeAlD
Probenecid—SLC22A8—cortex of kidney—kidney cancer	0.000308	0.00506	CbGeAlD
Probenecid—Leukopenia—Vinblastine—kidney cancer	0.000308	0.00503	CcSEcCtD
Probenecid—Decreased appetite—Pazopanib—kidney cancer	0.000308	0.00503	CcSEcCtD
Probenecid—Leukopenia—Everolimus—kidney cancer	0.000307	0.00501	CcSEcCtD
Probenecid—Flushing—Sunitinib—kidney cancer	0.000305	0.00499	CcSEcCtD
Probenecid—Pain—Pazopanib—kidney cancer	0.000303	0.00495	CcSEcCtD
Probenecid—Alopecia—Sorafenib—kidney cancer	0.000302	0.00493	CcSEcCtD
Probenecid—ABCC2—cortex of kidney—kidney cancer	0.000301	0.00494	CbGeAlD
Probenecid—Body temperature increased—Temsirolimus—kidney cancer	0.000297	0.00486	CcSEcCtD
Probenecid—Erythema multiforme—Dactinomycin—kidney cancer	0.000294	0.00481	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.000291	0.00476	CcSEcCtD
Probenecid—Alopecia—Sunitinib—kidney cancer	0.000291	0.00475	CcSEcCtD
Probenecid—Haemolytic anaemia—Capecitabine—kidney cancer	0.00029	0.00474	CcSEcCtD
Probenecid—Flushing—Dactinomycin—kidney cancer	0.000289	0.00472	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Paclitaxel—kidney cancer	0.000288	0.0047	CcSEcCtD
Probenecid—Haematuria—Gemcitabine—kidney cancer	0.00028	0.00458	CcSEcCtD
Probenecid—Hypersensitivity—Temsirolimus—kidney cancer	0.000277	0.00453	CcSEcCtD
Probenecid—Alopecia—Dactinomycin—kidney cancer	0.000275	0.00449	CcSEcCtD
Probenecid—Anaemia—Sorafenib—kidney cancer	0.000275	0.00449	CcSEcCtD
Probenecid—SLC22A5—nephron tubule—kidney cancer	0.000272	0.00447	CbGeAlD
Probenecid—Anorexia—Vinblastine—kidney cancer	0.000268	0.00437	CcSEcCtD
Probenecid—Anorexia—Everolimus—kidney cancer	0.000267	0.00436	CcSEcCtD
Probenecid—Leukopenia—Sorafenib—kidney cancer	0.000266	0.00435	CcSEcCtD
Probenecid—Pruritus—Temsirolimus—kidney cancer	0.000266	0.00435	CcSEcCtD
Probenecid—ABCC1—cortex of kidney—kidney cancer	0.000265	0.00435	CbGeAlD
Probenecid—Anaemia—Sunitinib—kidney cancer	0.000265	0.00432	CcSEcCtD
Probenecid—Procainamide—BCHE—kidney cancer	0.000263	0.153	CrCbGaD
Probenecid—Anorexia—Erlotinib—kidney cancer	0.000257	0.0042	CcSEcCtD
Probenecid—Leukopenia—Sunitinib—kidney cancer	0.000256	0.00419	CcSEcCtD
Probenecid—Pollakiuria—Paclitaxel—kidney cancer	0.000255	0.00417	CcSEcCtD
Probenecid—ABCC1—cardiac atrium—kidney cancer	0.000252	0.00414	CbGeAlD
Probenecid—Pruritus—Pazopanib—kidney cancer	0.000251	0.0041	CcSEcCtD
Probenecid—Anaemia—Dactinomycin—kidney cancer	0.00025	0.00409	CcSEcCtD
Probenecid—Erythema multiforme—Gemcitabine—kidney cancer	0.000249	0.00408	CcSEcCtD
Probenecid—Dizziness—Temsirolimus—kidney cancer	0.000249	0.00406	CcSEcCtD
Probenecid—SLC22A5—renal system—kidney cancer	0.000247	0.00406	CbGeAlD
Probenecid—Alopecia—Vincristine—kidney cancer	0.000246	0.00402	CcSEcCtD
Probenecid—Decreased appetite—Vinblastine—kidney cancer	0.000244	0.00399	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.000244	0.00399	CcSEcCtD
Probenecid—Decreased appetite—Everolimus—kidney cancer	0.000243	0.00397	CcSEcCtD
Probenecid—Anaphylactic shock—Sorafenib—kidney cancer	0.000243	0.00397	CcSEcCtD
Probenecid—Leukopenia—Dactinomycin—kidney cancer	0.000243	0.00396	CcSEcCtD
Probenecid—Pain—Vinblastine—kidney cancer	0.00024	0.00392	CcSEcCtD
Probenecid—CYP2C8—renal system—kidney cancer	0.000239	0.00393	CbGeAlD
Probenecid—Pain—Everolimus—kidney cancer	0.000239	0.00391	CcSEcCtD
Probenecid—SLC22A5—kidney—kidney cancer	0.000239	0.00393	CbGeAlD
Probenecid—Vomiting—Temsirolimus—kidney cancer	0.000239	0.00391	CcSEcCtD
Probenecid—Dermatitis—Temsirolimus—kidney cancer	0.000237	0.00387	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.000236	0.00386	CcSEcCtD
Probenecid—Headache—Temsirolimus—kidney cancer	0.000236	0.00385	CcSEcCtD
Probenecid—Haematuria—Paclitaxel—kidney cancer	0.000235	0.00383	CcSEcCtD
Probenecid—Decreased appetite—Erlotinib—kidney cancer	0.000235	0.00383	CcSEcCtD
Probenecid—Dizziness—Pazopanib—kidney cancer	0.000234	0.00383	CcSEcCtD
Probenecid—Alopecia—Gemcitabine—kidney cancer	0.000233	0.00381	CcSEcCtD
Probenecid—SLC22A5—cortex of kidney—kidney cancer	0.000233	0.00383	CbGeAlD
Probenecid—CYP2C8—kidney—kidney cancer	0.000231	0.0038	CbGeAlD
Probenecid—Anorexia—Sorafenib—kidney cancer	0.000231	0.00378	CcSEcCtD
Probenecid—Pain—Erlotinib—kidney cancer	0.000231	0.00377	CcSEcCtD
Probenecid—Vomiting—Pazopanib—kidney cancer	0.000225	0.00368	CcSEcCtD
Probenecid—Anaemia—Vincristine—kidney cancer	0.000224	0.00366	CcSEcCtD
Probenecid—Nausea—Temsirolimus—kidney cancer	0.000223	0.00365	CcSEcCtD
Probenecid—Dermatitis—Pazopanib—kidney cancer	0.000223	0.00365	CcSEcCtD
Probenecid—Anorexia—Sunitinib—kidney cancer	0.000223	0.00364	CcSEcCtD
Probenecid—Headache—Pazopanib—kidney cancer	0.000222	0.00363	CcSEcCtD
Probenecid—SLC22A5—cardiac atrium—kidney cancer	0.000221	0.00364	CbGeAlD
Probenecid—Body temperature increased—Everolimus—kidney cancer	0.000221	0.00361	CcSEcCtD
Probenecid—Aplastic anaemia—Doxorubicin—kidney cancer	0.000218	0.00357	CcSEcCtD
Probenecid—Leukopenia—Vincristine—kidney cancer	0.000217	0.00354	CcSEcCtD
Probenecid—Body temperature increased—Erlotinib—kidney cancer	0.000213	0.00349	CcSEcCtD
Probenecid—Anaemia—Gemcitabine—kidney cancer	0.000212	0.00347	CcSEcCtD
Probenecid—Decreased appetite—Sorafenib—kidney cancer	0.000211	0.00345	CcSEcCtD
Probenecid—Anorexia—Dactinomycin—kidney cancer	0.000211	0.00344	CcSEcCtD
Probenecid—Nausea—Pazopanib—kidney cancer	0.00021	0.00344	CcSEcCtD
Probenecid—Erythema multiforme—Paclitaxel—kidney cancer	0.000209	0.00341	CcSEcCtD
Probenecid—Pain—Sorafenib—kidney cancer	0.000208	0.00339	CcSEcCtD
Probenecid—Hypersensitivity—Vinblastine—kidney cancer	0.000207	0.00338	CcSEcCtD
Probenecid—Hypersensitivity—Everolimus—kidney cancer	0.000206	0.00337	CcSEcCtD
Probenecid—Leukopenia—Gemcitabine—kidney cancer	0.000206	0.00336	CcSEcCtD
Probenecid—Flushing—Paclitaxel—kidney cancer	0.000205	0.00335	CcSEcCtD
Probenecid—Decreased appetite—Sunitinib—kidney cancer	0.000203	0.00332	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.0002	0.00327	CcSEcCtD
Probenecid—Pain—Sunitinib—kidney cancer	0.0002	0.00326	CcSEcCtD
Probenecid—Pruritus—Everolimus—kidney cancer	0.000198	0.00323	CcSEcCtD
Probenecid—Anaphylactic shock—Vincristine—kidney cancer	0.000198	0.00323	CcSEcCtD
Probenecid—Alopecia—Paclitaxel—kidney cancer	0.000195	0.00319	CcSEcCtD
Probenecid—Urticaria—Sorafenib—kidney cancer	0.000193	0.00315	CcSEcCtD
Probenecid—Haematuria—Capecitabine—kidney cancer	0.000193	0.00315	CcSEcCtD
Probenecid—Decreased appetite—Dactinomycin—kidney cancer	0.000192	0.00314	CcSEcCtD
Probenecid—Body temperature increased—Sorafenib—kidney cancer	0.000192	0.00314	CcSEcCtD
Probenecid—Pruritus—Erlotinib—kidney cancer	0.000191	0.00312	CcSEcCtD
Probenecid—Pain—Dactinomycin—kidney cancer	0.000189	0.00309	CcSEcCtD
Probenecid—Anorexia—Vincristine—kidney cancer	0.000188	0.00308	CcSEcCtD
Probenecid—Anaphylactic shock—Gemcitabine—kidney cancer	0.000187	0.00306	CcSEcCtD
Probenecid—Dizziness—Vinblastine—kidney cancer	0.000186	0.00303	CcSEcCtD
Probenecid—Dizziness—Everolimus—kidney cancer	0.000185	0.00302	CcSEcCtD
Probenecid—Body temperature increased—Sunitinib—kidney cancer	0.000185	0.00302	CcSEcCtD
Probenecid—Hypersensitivity—Sorafenib—kidney cancer	0.000179	0.00292	CcSEcCtD
Probenecid—Anorexia—Gemcitabine—kidney cancer	0.000179	0.00292	CcSEcCtD
Probenecid—Vomiting—Vinblastine—kidney cancer	0.000179	0.00292	CcSEcCtD
Probenecid—Dizziness—Erlotinib—kidney cancer	0.000178	0.00292	CcSEcCtD
Probenecid—Vomiting—Everolimus—kidney cancer	0.000178	0.00291	CcSEcCtD
Probenecid—Anaemia—Paclitaxel—kidney cancer	0.000178	0.0029	CcSEcCtD
Probenecid—Dermatitis—Everolimus—kidney cancer	0.000176	0.00288	CcSEcCtD
Probenecid—Headache—Vinblastine—kidney cancer	0.000176	0.00287	CcSEcCtD
Probenecid—Headache—Everolimus—kidney cancer	0.000175	0.00286	CcSEcCtD
Probenecid—Body temperature increased—Dactinomycin—kidney cancer	0.000175	0.00286	CcSEcCtD
Probenecid—Leukopenia—Paclitaxel—kidney cancer	0.000172	0.00281	CcSEcCtD
Probenecid—Hypersensitivity—Sunitinib—kidney cancer	0.000172	0.00281	CcSEcCtD
Probenecid—Decreased appetite—Vincristine—kidney cancer	0.000172	0.00281	CcSEcCtD
Probenecid—Pruritus—Sorafenib—kidney cancer	0.000172	0.00281	CcSEcCtD
Probenecid—Vomiting—Erlotinib—kidney cancer	0.000172	0.0028	CcSEcCtD
Probenecid—Erythema multiforme—Capecitabine—kidney cancer	0.000171	0.0028	CcSEcCtD
Probenecid—Dermatitis—Erlotinib—kidney cancer	0.00017	0.00278	CcSEcCtD
Probenecid—Headache—Erlotinib—kidney cancer	0.000169	0.00276	CcSEcCtD
Probenecid—Pain—Vincristine—kidney cancer	0.000169	0.00276	CcSEcCtD
Probenecid—Flushing—Capecitabine—kidney cancer	0.000168	0.00275	CcSEcCtD
Probenecid—Nausea—Vinblastine—kidney cancer	0.000167	0.00273	CcSEcCtD
Probenecid—Nausea—Everolimus—kidney cancer	0.000166	0.00271	CcSEcCtD
Probenecid—Pruritus—Sunitinib—kidney cancer	0.000165	0.0027	CcSEcCtD
Probenecid—Decreased appetite—Gemcitabine—kidney cancer	0.000163	0.00266	CcSEcCtD
Probenecid—Hypersensitivity—Dactinomycin—kidney cancer	0.000163	0.00266	CcSEcCtD
Probenecid—Chlorpropamide—ABCB1—kidney cancer	0.000163	0.0946	CrCbGaD
Probenecid—CYP3A4—renal system—kidney cancer	0.000162	0.00266	CbGeAlD
Probenecid—Dizziness—Sorafenib—kidney cancer	0.000161	0.00262	CcSEcCtD
Probenecid—Pain—Gemcitabine—kidney cancer	0.00016	0.00262	CcSEcCtD
Probenecid—Nausea—Erlotinib—kidney cancer	0.00016	0.00262	CcSEcCtD
Probenecid—Alopecia—Capecitabine—kidney cancer	0.00016	0.00262	CcSEcCtD
Probenecid—Anaphylactic shock—Paclitaxel—kidney cancer	0.000157	0.00256	CcSEcCtD
Probenecid—CYP3A4—kidney—kidney cancer	0.000157	0.00258	CbGeAlD
Probenecid—Body temperature increased—Vincristine—kidney cancer	0.000156	0.00255	CcSEcCtD
Probenecid—Dizziness—Sunitinib—kidney cancer	0.000154	0.00252	CcSEcCtD
Probenecid—Vomiting—Sorafenib—kidney cancer	0.000154	0.00252	CcSEcCtD
Probenecid—Dermatitis—Sorafenib—kidney cancer	0.000153	0.0025	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000152	0.00249	CcSEcCtD
Probenecid—Headache—Sorafenib—kidney cancer	0.000152	0.00249	CcSEcCtD
Probenecid—Anorexia—Paclitaxel—kidney cancer	0.00015	0.00244	CcSEcCtD
Probenecid—Vomiting—Sunitinib—kidney cancer	0.000149	0.00243	CcSEcCtD
Probenecid—Body temperature increased—Gemcitabine—kidney cancer	0.000148	0.00242	CcSEcCtD
Probenecid—Dermatitis—Sunitinib—kidney cancer	0.000147	0.0024	CcSEcCtD
Probenecid—Headache—Sunitinib—kidney cancer	0.000146	0.00239	CcSEcCtD
Probenecid—Anaemia—Capecitabine—kidney cancer	0.000146	0.00238	CcSEcCtD
Probenecid—Hypersensitivity—Vincristine—kidney cancer	0.000146	0.00238	CcSEcCtD
Probenecid—Nausea—Sorafenib—kidney cancer	0.000144	0.00236	CcSEcCtD
Probenecid—Leukopenia—Capecitabine—kidney cancer	0.000141	0.00231	CcSEcCtD
Probenecid—Vomiting—Dactinomycin—kidney cancer	0.000141	0.0023	CcSEcCtD
Probenecid—Nausea—Sunitinib—kidney cancer	0.000139	0.00227	CcSEcCtD
Probenecid—Decreased appetite—Paclitaxel—kidney cancer	0.000136	0.00223	CcSEcCtD
Probenecid—Pollakiuria—Doxorubicin—kidney cancer	0.000135	0.0022	CcSEcCtD
Probenecid—Pain—Paclitaxel—kidney cancer	0.000134	0.00219	CcSEcCtD
Probenecid—Pruritus—Gemcitabine—kidney cancer	0.000133	0.00217	CcSEcCtD
Probenecid—Nausea—Dactinomycin—kidney cancer	0.000131	0.00215	CcSEcCtD
Probenecid—Dizziness—Vincristine—kidney cancer	0.000131	0.00214	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000129	0.00211	CcSEcCtD
Probenecid—ABCB1—nephron tubule—kidney cancer	0.000126	0.00207	CbGeAlD
Probenecid—Vomiting—Vincristine—kidney cancer	0.000126	0.00205	CcSEcCtD
Probenecid—Urticaria—Paclitaxel—kidney cancer	0.000125	0.00204	CcSEcCtD
Probenecid—Dermatitis—Vincristine—kidney cancer	0.000124	0.00203	CcSEcCtD
Probenecid—Haematuria—Doxorubicin—kidney cancer	0.000124	0.00203	CcSEcCtD
Probenecid—Body temperature increased—Paclitaxel—kidney cancer	0.000124	0.00203	CcSEcCtD
Probenecid—Headache—Vincristine—kidney cancer	0.000124	0.00202	CcSEcCtD
Probenecid—Anorexia—Capecitabine—kidney cancer	0.000123	0.00201	CcSEcCtD
Probenecid—Vomiting—Gemcitabine—kidney cancer	0.000119	0.00195	CcSEcCtD
Probenecid—Dermatitis—Gemcitabine—kidney cancer	0.000118	0.00193	CcSEcCtD
Probenecid—Headache—Gemcitabine—kidney cancer	0.000117	0.00192	CcSEcCtD
Probenecid—Nausea—Vincristine—kidney cancer	0.000117	0.00192	CcSEcCtD
Probenecid—Hypersensitivity—Paclitaxel—kidney cancer	0.000116	0.00189	CcSEcCtD
Probenecid—ABCB1—renal system—kidney cancer	0.000115	0.00189	CbGeAlD
Probenecid—Decreased appetite—Capecitabine—kidney cancer	0.000112	0.00183	CcSEcCtD
Probenecid—Nausea—Gemcitabine—kidney cancer	0.000111	0.00182	CcSEcCtD
Probenecid—Pruritus—Paclitaxel—kidney cancer	0.000111	0.00181	CcSEcCtD
Probenecid—ABCB1—kidney—kidney cancer	0.000111	0.00182	CbGeAlD
Probenecid—Erythema multiforme—Doxorubicin—kidney cancer	0.00011	0.00181	CcSEcCtD
Probenecid—Pain—Capecitabine—kidney cancer	0.00011	0.0018	CcSEcCtD
Probenecid—Flushing—Doxorubicin—kidney cancer	0.000108	0.00177	CcSEcCtD
Probenecid—ABCB1—cortex of kidney—kidney cancer	0.000108	0.00178	CbGeAlD
Probenecid—Dizziness—Paclitaxel—kidney cancer	0.000104	0.0017	CcSEcCtD
Probenecid—Alopecia—Doxorubicin—kidney cancer	0.000103	0.00169	CcSEcCtD
Probenecid—ABCB1—gonad—kidney cancer	0.000103	0.00169	CbGeAlD
Probenecid—Urticaria—Capecitabine—kidney cancer	0.000102	0.00167	CcSEcCtD
Probenecid—Body temperature increased—Capecitabine—kidney cancer	0.000102	0.00166	CcSEcCtD
Probenecid—Vomiting—Paclitaxel—kidney cancer	9.98e-05	0.00163	CcSEcCtD
Probenecid—Dermatitis—Paclitaxel—kidney cancer	9.89e-05	0.00162	CcSEcCtD
Probenecid—Headache—Paclitaxel—kidney cancer	9.83e-05	0.00161	CcSEcCtD
Probenecid—Hypersensitivity—Capecitabine—kidney cancer	9.49e-05	0.00155	CcSEcCtD
Probenecid—Anaemia—Doxorubicin—kidney cancer	9.4e-05	0.00154	CcSEcCtD
Probenecid—Nausea—Paclitaxel—kidney cancer	9.32e-05	0.00152	CcSEcCtD
Probenecid—Pruritus—Capecitabine—kidney cancer	9.11e-05	0.00149	CcSEcCtD
Probenecid—Leukopenia—Doxorubicin—kidney cancer	9.11e-05	0.00149	CcSEcCtD
Probenecid—Dizziness—Capecitabine—kidney cancer	8.52e-05	0.00139	CcSEcCtD
Probenecid—Anaphylactic shock—Doxorubicin—kidney cancer	8.3e-05	0.00136	CcSEcCtD
Probenecid—Vomiting—Capecitabine—kidney cancer	8.19e-05	0.00134	CcSEcCtD
Probenecid—Dermatitis—Capecitabine—kidney cancer	8.11e-05	0.00133	CcSEcCtD
Probenecid—Headache—Capecitabine—kidney cancer	8.07e-05	0.00132	CcSEcCtD
Probenecid—Anorexia—Doxorubicin—kidney cancer	7.91e-05	0.00129	CcSEcCtD
Probenecid—Nausea—Capecitabine—kidney cancer	7.65e-05	0.00125	CcSEcCtD
Probenecid—Decreased appetite—Doxorubicin—kidney cancer	7.22e-05	0.00118	CcSEcCtD
Probenecid—Pain—Doxorubicin—kidney cancer	7.1e-05	0.00116	CcSEcCtD
Probenecid—Urticaria—Doxorubicin—kidney cancer	6.6e-05	0.00108	CcSEcCtD
Probenecid—Body temperature increased—Doxorubicin—kidney cancer	6.56e-05	0.00107	CcSEcCtD
Probenecid—Hypersensitivity—Doxorubicin—kidney cancer	6.12e-05	0.000999	CcSEcCtD
Probenecid—Pruritus—Doxorubicin—kidney cancer	5.87e-05	0.00096	CcSEcCtD
Probenecid—Dizziness—Doxorubicin—kidney cancer	5.49e-05	0.000897	CcSEcCtD
Probenecid—Vomiting—Doxorubicin—kidney cancer	5.28e-05	0.000863	CcSEcCtD
Probenecid—Dermatitis—Doxorubicin—kidney cancer	5.23e-05	0.000855	CcSEcCtD
Probenecid—Headache—Doxorubicin—kidney cancer	5.2e-05	0.00085	CcSEcCtD
Probenecid—Nausea—Doxorubicin—kidney cancer	4.93e-05	0.000806	CcSEcCtD
Probenecid—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.25e-06	9.16e-05	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	5.25e-06	9.15e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—ABCB1—kidney cancer	5.2e-06	9.08e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CCBL1—kidney cancer	5.19e-06	9.06e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PGK1—kidney cancer	5.18e-06	9.03e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SLC5A3—kidney cancer	5.18e-06	9.03e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—POMC—kidney cancer	5.17e-06	9.02e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—SLC2A1—kidney cancer	5.17e-06	9.01e-05	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	5.16e-06	9.01e-05	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—KRAS—kidney cancer	5.08e-06	8.86e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—LDHB—kidney cancer	5.08e-06	8.85e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—GSTM1—kidney cancer	5.05e-06	8.81e-05	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—PTEN—kidney cancer	5.05e-06	8.8e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—BCHE—kidney cancer	5.05e-06	8.8e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.02e-06	8.75e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—CDKN1B—kidney cancer	5.02e-06	8.75e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—SLC5A5—kidney cancer	4.98e-06	8.69e-05	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	4.96e-06	8.65e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—GSTP1—kidney cancer	4.95e-06	8.63e-05	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—RAF1—kidney cancer	4.93e-06	8.59e-05	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	4.89e-06	8.52e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CA9—kidney cancer	4.83e-06	8.42e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—SLC2A1—kidney cancer	4.81e-06	8.4e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—CYP1A1—kidney cancer	4.79e-06	8.35e-05	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	4.75e-06	8.29e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—CTNNB1—kidney cancer	4.74e-06	8.27e-05	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	4.72e-06	8.23e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.72e-06	8.23e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CA9—kidney cancer	4.71e-06	8.21e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—ABCB1—kidney cancer	4.68e-06	8.17e-05	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—PIK3CA—kidney cancer	4.67e-06	8.14e-05	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	4.65e-06	8.11e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—PTEN—kidney cancer	4.62e-06	8.06e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CRABP1—kidney cancer	4.6e-06	8.02e-05	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.59e-06	8.01e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—HIF1A—kidney cancer	4.58e-06	7.98e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CRABP1—kidney cancer	4.57e-06	7.97e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—TSC2—kidney cancer	4.56e-06	7.96e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—GSTM1—kidney cancer	4.55e-06	7.93e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.52e-06	7.88e-05	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—TP53—kidney cancer	4.51e-06	7.87e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PPAT—kidney cancer	4.5e-06	7.85e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GLIPR1—kidney cancer	4.5e-06	7.85e-05	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PTGS2—kidney cancer	4.44e-06	7.74e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CA9—kidney cancer	4.4e-06	7.67e-05	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	4.39e-06	7.66e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—CYP1A1—kidney cancer	4.31e-06	7.52e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—GSTP1—kidney cancer	4.31e-06	7.51e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.3e-06	7.5e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ITPR2—kidney cancer	4.27e-06	7.45e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—ITPR2—kidney cancer	4.25e-06	7.41e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—FH—kidney cancer	4.19e-06	7.3e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—APRT—kidney cancer	4.19e-06	7.3e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PTGS2—kidney cancer	4.12e-06	7.19e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CRABP1—kidney cancer	4.1e-06	7.16e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—POMC—kidney cancer	4.1e-06	7.15e-05	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	4.1e-06	7.14e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—ABCB1—kidney cancer	4.08e-06	7.11e-05	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	4.03e-06	7.03e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—APC—kidney cancer	4.03e-06	7.03e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—KIT—kidney cancer	4.03e-06	7.03e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—GSTP1—kidney cancer	4.02e-06	7e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CRABP1—kidney cancer	4.01e-06	6.98e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—GSTM1—kidney cancer	3.96e-06	6.9e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—MAPK3—kidney cancer	3.95e-06	6.88e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.94e-06	6.87e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GPC3—kidney cancer	3.94e-06	6.86e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.93e-06	6.86e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.92e-06	6.83e-05	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	3.9e-06	6.81e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GSTT1—kidney cancer	3.9e-06	6.8e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ACHE—kidney cancer	3.9e-06	6.8e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GSTT1—kidney cancer	3.88e-06	6.76e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—ACHE—kidney cancer	3.88e-06	6.76e-05	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PTEN—kidney cancer	3.87e-06	6.75e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—MYC—kidney cancer	3.84e-06	6.7e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CA2—kidney cancer	3.83e-06	6.68e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ITPR2—kidney cancer	3.81e-06	6.65e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—ABCB1—kidney cancer	3.8e-06	6.63e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—BRAF—kidney cancer	3.79e-06	6.61e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—MAPK1—kidney cancer	3.76e-06	6.55e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CYP1A1—kidney cancer	3.75e-06	6.55e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CRABP1—kidney cancer	3.74e-06	6.53e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALAD—kidney cancer	3.73e-06	6.51e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ITPR2—kidney cancer	3.72e-06	6.49e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—GSTM1—kidney cancer	3.69e-06	6.44e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—SCARB1—kidney cancer	3.69e-06	6.43e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—SCARB1—kidney cancer	3.67e-06	6.4e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTGS1—kidney cancer	3.65e-06	6.37e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ST3GAL2—kidney cancer	3.64e-06	6.35e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTGS1—kidney cancer	3.63e-06	6.33e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PTEN—kidney cancer	3.6e-06	6.27e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PSMD7—kidney cancer	3.58e-06	6.25e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—POMC—kidney cancer	3.57e-06	6.23e-05	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—PIK3CA—kidney cancer	3.56e-06	6.21e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PSMD7—kidney cancer	3.56e-06	6.21e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALDH1A1—kidney cancer	3.56e-06	6.21e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—RAF1—kidney cancer	3.55e-06	6.19e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—KRAS—kidney cancer	3.55e-06	6.19e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.54e-06	6.17e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.52e-06	6.13e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CYP1A1—kidney cancer	3.5e-06	6.1e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ACHE—kidney cancer	3.48e-06	6.07e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GSTT1—kidney cancer	3.48e-06	6.07e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ITPR2—kidney cancer	3.48e-06	6.07e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PGK1—kidney cancer	3.41e-06	5.95e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.41e-06	5.95e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ACHE—kidney cancer	3.4e-06	5.92e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GSTT1—kidney cancer	3.4e-06	5.92e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—BCHE—kidney cancer	3.4e-06	5.92e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—BCHE—kidney cancer	3.38e-06	5.89e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—SLC5A5—kidney cancer	3.35e-06	5.85e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—LDHB—kidney cancer	3.35e-06	5.84e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—SLC5A5—kidney cancer	3.33e-06	5.82e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—SCARB1—kidney cancer	3.29e-06	5.74e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PTGS2—kidney cancer	3.27e-06	5.7e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTGS1—kidney cancer	3.26e-06	5.68e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—PIK3CA—kidney cancer	3.26e-06	5.68e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—SLC2A1—kidney cancer	3.24e-06	5.65e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—SLC2A1—kidney cancer	3.22e-06	5.62e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—SCARB1—kidney cancer	3.21e-06	5.61e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—POMC—kidney cancer	3.21e-06	5.6e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.21e-06	5.59e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PSMD7—kidney cancer	3.2e-06	5.58e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTGS1—kidney cancer	3.18e-06	5.55e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—IL2—kidney cancer	3.18e-06	5.55e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ACHE—kidney cancer	3.17e-06	5.53e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GSTT1—kidney cancer	3.17e-06	5.53e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—RAF1—kidney cancer	3.16e-06	5.52e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.14e-06	5.48e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—ERBB2—kidney cancer	3.13e-06	5.46e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.12e-06	5.45e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PSMD7—kidney cancer	3.12e-06	5.44e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MTOR—kidney cancer	3.09e-06	5.39e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—CD4—kidney cancer	3.08e-06	5.38e-05	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	3.07e-06	5.36e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTGS2—kidney cancer	3.06e-06	5.34e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—BCHE—kidney cancer	3.03e-06	5.29e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SCARB1—kidney cancer	3e-06	5.24e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—SLC5A5—kidney cancer	2.99e-06	5.22e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTGS1—kidney cancer	2.97e-06	5.18e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—BCHE—kidney cancer	2.96e-06	5.16e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—SLC5A5—kidney cancer	2.92e-06	5.1e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PSMD7—kidney cancer	2.91e-06	5.08e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CA9—kidney cancer	2.9e-06	5.06e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—CDKN1B—kidney cancer	2.9e-06	5.05e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—SLC2A1—kidney cancer	2.89e-06	5.04e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PTEN—kidney cancer	2.85e-06	4.97e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PTGS2—kidney cancer	2.85e-06	4.97e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—SLC2A1—kidney cancer	2.82e-06	4.92e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.81e-06	4.89e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—POMC—kidney cancer	2.8e-06	4.88e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—BCHE—kidney cancer	2.76e-06	4.82e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.74e-06	4.78e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—CTNNB1—kidney cancer	2.74e-06	4.78e-05	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PIK3CA—kidney cancer	2.73e-06	4.76e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SLC5A5—kidney cancer	2.73e-06	4.76e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.73e-06	4.75e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—VEGFA—kidney cancer	2.7e-06	4.71e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GSTP1—kidney cancer	2.7e-06	4.71e-05	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.69e-06	4.69e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GSTP1—kidney cancer	2.69e-06	4.68e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTEN—kidney cancer	2.67e-06	4.65e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SLC2A1—kidney cancer	2.64e-06	4.6e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—POMC—kidney cancer	2.61e-06	4.55e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTGS2—kidney cancer	2.56e-06	4.47e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.56e-06	4.46e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—MAPK3—kidney cancer	2.56e-06	4.46e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ABCB1—kidney cancer	2.56e-06	4.46e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—ABCB1—kidney cancer	2.54e-06	4.43e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PIK3CA—kidney cancer	2.54e-06	4.43e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PTEN—kidney cancer	2.48e-06	4.33e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GSTM1—kidney cancer	2.48e-06	4.33e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GSTM1—kidney cancer	2.47e-06	4.3e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CRABP1—kidney cancer	2.47e-06	4.3e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.45e-06	4.27e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—MAPK1—kidney cancer	2.43e-06	4.24e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GSTP1—kidney cancer	2.41e-06	4.21e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GSTP1—kidney cancer	2.35e-06	4.1e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYP1A1—kidney cancer	2.35e-06	4.1e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYP1A1—kidney cancer	2.34e-06	4.08e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—KRAS—kidney cancer	2.3e-06	4.01e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ITPR2—kidney cancer	2.29e-06	4e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ABCB1—kidney cancer	2.28e-06	3.98e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MAPK3—kidney cancer	2.28e-06	3.98e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTEN—kidney cancer	2.24e-06	3.9e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTGS2—kidney cancer	2.23e-06	3.89e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.23e-06	3.89e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MYC—kidney cancer	2.22e-06	3.87e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GSTM1—kidney cancer	2.22e-06	3.86e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GSTP1—kidney cancer	2.2e-06	3.83e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MAPK1—kidney cancer	2.17e-06	3.78e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GSTM1—kidney cancer	2.16e-06	3.77e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PIK3CA—kidney cancer	2.11e-06	3.68e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP1A1—kidney cancer	2.1e-06	3.66e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ACHE—kidney cancer	2.09e-06	3.65e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTT1—kidney cancer	2.09e-06	3.65e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ABCB1—kidney cancer	2.08e-06	3.63e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTGS2—kidney cancer	2.08e-06	3.63e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP1A1—kidney cancer	2.05e-06	3.58e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—KRAS—kidney cancer	2.05e-06	3.57e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TP53—kidney cancer	2.04e-06	3.56e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GSTM1—kidney cancer	2.02e-06	3.52e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CA—kidney cancer	2.01e-06	3.51e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SCARB1—kidney cancer	1.98e-06	3.45e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTGS1—kidney cancer	1.96e-06	3.42e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTEN—kidney cancer	1.95e-06	3.39e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.93e-06	3.37e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.92e-06	3.35e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PSMD7—kidney cancer	1.92e-06	3.35e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.92e-06	3.34e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PIK3CA—kidney cancer	1.88e-06	3.28e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—BCHE—kidney cancer	1.82e-06	3.18e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTEN—kidney cancer	1.81e-06	3.16e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.8e-06	3.14e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—POMC—kidney cancer	1.75e-06	3.06e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CA—kidney cancer	1.75e-06	3.06e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—POMC—kidney cancer	1.74e-06	3.04e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.74e-06	3.03e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.73e-06	3.01e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CA—kidney cancer	1.58e-06	2.75e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.57e-06	2.74e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—POMC—kidney cancer	1.57e-06	2.73e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—POMC—kidney cancer	1.53e-06	2.67e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTP1—kidney cancer	1.45e-06	2.53e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—POMC—kidney cancer	1.43e-06	2.49e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTGS2—kidney cancer	1.4e-06	2.44e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTGS2—kidney cancer	1.39e-06	2.43e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CA—kidney cancer	1.37e-06	2.39e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ABCB1—kidney cancer	1.37e-06	2.39e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTM1—kidney cancer	1.33e-06	2.32e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CA—kidney cancer	1.28e-06	2.23e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.26e-06	2.2e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTGS2—kidney cancer	1.25e-06	2.18e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTEN—kidney cancer	1.22e-06	2.13e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTGS2—kidney cancer	1.22e-06	2.13e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTEN—kidney cancer	1.21e-06	2.12e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTGS2—kidney cancer	1.14e-06	1.99e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTEN—kidney cancer	1.09e-06	1.9e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTEN—kidney cancer	1.06e-06	1.85e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTEN—kidney cancer	9.93e-07	1.73e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—POMC—kidney cancer	9.42e-07	1.64e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CA—kidney cancer	8.61e-07	1.5e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CA—kidney cancer	8.56e-07	1.49e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CA—kidney cancer	7.69e-07	1.34e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTGS2—kidney cancer	7.51e-07	1.31e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CA—kidney cancer	7.5e-07	1.31e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CA—kidney cancer	7.01e-07	1.22e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTEN—kidney cancer	6.55e-07	1.14e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CA—kidney cancer	4.62e-07	8.06e-06	CbGpPWpGaD
